Chemical Compound Review:
AGN-PC-00QXRC [2-methoxy-3-[oxido-[2-(1,3- thiazol-3...
Synonyms:
CHEMBL295212, AG-H-45346, SureCN8701203, C7238_SIGMA, CV-3988, ...
This record was replaced with 107682.
- Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats. Chang, S.W., Feddersen, C.O., Henson, P.M., Voelkel, N.F. J. Clin. Invest. (1987)
- PAF produced by human breast cancer cells promotes migration and proliferation of tumor cells and neo-angiogenesis. Bussolati, B., Biancone, L., Cassoni, P., Russo, S., Rola-Pleszczynski, M., Montrucchio, G., Camussi, G. Am. J. Pathol. (2000)
- Role of acetyl glyceryl ether phosphorylcholine in blood pressure regulation in rats. Masugi, F., Ogihara, T., Saeki, S., Otsuka, A., Kumahara, Y. Hypertension (1985)
- A lethal role of platelet activating factor in anaphylactic shock in mice. Terashita, Z., Imura, Y., Shino, A., Nishikawa, K. J. Pharmacol. Exp. Ther. (1987)
- Evidence for a role of platelet activating factor in the pathogenesis of irreversible but not reversible myocardial injury after reperfusion in dogs. Maruyama, M., Farber, N.E., Vercellotti, G.M., Jacob, H.S., Gross, G.J. Am. Heart J. (1990)
- Evidence for platelet-activating factor as a mediator of endotoxin-induced gastrointestinal damage in the rat. Effects of three platelet-activating factor antagonists. Wallace, J.L., Steel, G., Whittle, B.J., Lagente, V., Vargaftig, B. Gastroenterology (1987)
- Anti-apoptotic actions of the platelet-activating factor acetylhydrolase I alpha2 catalytic subunit. Bonin, F., Ryan, S.D., Migahed, L., Mo, F., Lallier, J., Franks, D.J., Arai, H., Bennett, S.A. J. Biol. Chem. (2004)
- Platelet-activating factor synthesized by IL-12-stimulated polymorphonuclear neutrophils and NK cells mediates chemotaxis. Bussolati, B., Mariano, F., Cignetti, A., Guarini, A., Cambi, V., Foà, R., Piccoli, G., Camussi, G. J. Immunol. (1998)
- Existence of endogenous inhibitors of platelet-activating factor (PAF) with PAF in rat uterus. Nakayama, R., Yasuda, K., Saito, K. J. Biol. Chem. (1987)
- Effects of the platelet-activating factor antagonists CV-6209 and CV-3988 on nephrotoxic serum nephritis in the rat. Iida, H., Fujita, M., Izumino, K., Asaka, M., Entani, C., Takata, M., Sasayama, S. Nephron (1992)
- The effects of platelet-activating factor (PAF) and a PAF antagonist (CV-3988) on smoke inhalation injury in an ovine model. Ikeuchi, H., Sakano, T., Sanchez, J., Mason, A.D., Pruitt, B.A. The Journal of trauma. (1992)
- Gastrointestinal plasma leakage in endotoxic shock. Inhibition by prostaglandin E2 and by a platelet-activating factor antagonist. Wallace, J.L., Steel, G., Whittle, B.J. Can. J. Physiol. Pharmacol. (1987)
- Platelet-activating factor contributes to postischemic vasospasm. Wang, W.Z., Guo, S.Z., Tsai, T.M., Anderson, G.L., Miller, F.N. J. Surg. Res. (2000)
- Structural analogs of alkylacetylglycerophosphocholine inhibitory behavior on platelet activation. Tokumura, A., Homma, H., Hanahan, D.J. J. Biol. Chem. (1985)
- CV-6209, a highly potent antagonist of platelet activating factor in vitro and in vivo. Terashita, Z., Imura, Y., Takatani, M., Tsushima, S., Nishikawa, K. J. Pharmacol. Exp. Ther. (1987)
- Effects of platelet activating factor on human sperm function in vitro. Sengoku, K., Tamate, K., Takaoka, Y., Ishikawa, M. Hum. Reprod. (1993)
- PAF binding to a single receptor in corneal epithelium plasma membrane. Hurst, J., Ma, X., Bazan, H.E. Invest. Ophthalmol. Vis. Sci. (1999)
- The synthesis of platelet-activating factor modulates chemotaxis of monocytes induced by HIV-1 Tat. Del Sorbo, L., DeMartino, A., Biancone, L., Bussolati, B., Conaldi, P.G., Toniolo, A., Camussi, G. Eur. J. Immunol. (1999)
- Antagonism of platelet-activating factor in isolated rat colon: possible mechanism. Tokumura, A., Yube, N., Terao, M., Tsukatani, H. Lipids (1991)
- Study of platelet activating factor and its antagonists on rat colon strip with a new method avoiding tachyphylaxis. Tokumura, A., Terao, M., Okamoto, M., Yoshida, K., Tsukatani, H. Eur. J. Pharmacol. (1988)
- trans-2,5-Bis-(3,4,5-trimethoxyphenyl)tetrahydrofuran. An orally active specific and competitive receptor antagonist of platelet activating factor. Hwang, S.B., Lam, M.H., Biftu, T., Beattie, T.R., Shen, T.Y. J. Biol. Chem. (1985)
- Evaluation of PAF antagonists using human neutrophils in a microtiter plate assay. Dewald, B., Baggiolini, M. Biochem. Pharmacol. (1987)
- Inhibition by CV-3988 of the binding of [3H]-platelet activating factor (PAF) to the platelet. Terashita, Z., Imura, Y., Nishikawa, K. Biochem. Pharmacol. (1985)
- Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors kadsurenone and CV 3988. Nunez, D., Chignard, M., Korth, R., Le Couedic, J.P., Norel, X., Spinnewyn, B., Braquet, P., Benveniste, J. Eur. J. Pharmacol. (1986)
- 1-O-hexadec-1'-enyl-2-acetyl-sn-glycero-3-phosphocholine and its biological activity. Nakayama, R., Yasuda, K., Satouchi, K., Saito, K. Biochem. Biophys. Res. Commun. (1988)
- Differential effects of interleukin-2 and interleukin-4 on immunomodulatory role of platelet-activating factor in human B cells. Patke, C.L., Green, C.G., Shearer, W.T. Clin. Diagn. Lab. Immunol. (1994)
- Levalbuterol inhibits human airway smooth muscle cell proliferation: therapeutic implications in the management of asthma. Ibe, B.O., Portugal, A.M., Raj, J.U. Int. Arch. Allergy Immunol. (2006)
- Platelet-activating factor enhances interleukin-6 production by alveolar macrophages. Thivierge, M., Rola-Pleszczynski, M. J. Allergy Clin. Immunol. (1992)
- Platelet-activating factor in vasoobliteration of oxygen-induced retinopathy. Beauchamp, M.H., Marrache, A.M., Hou, X., Gobeil, F., Bernier, S.G., Lachapelle, P., Abran, D., Quiniou, C., Brault, S., Peri, K.G., Roberts, J., Almazan, G., Varma, D.R., Chemtob, S. Invest. Ophthalmol. Vis. Sci. (2002)
- Role of nitric oxide and platelet-activating factor in cardiac alterations induced by tumor necrosis factor-alpha in the guinea-pig papillary muscle. Alloatti, G., Penna, C., De Martino, A., Montrucchio, G., Camussi, G. Cardiovasc. Res. (1999)
- Effects of platelet-activating factor antagonist CV-3988 in preservation of heart and lung for transplantation. Qayumi, A.K., Jamieson, W.R., Poostizadeh, A. Ann. Thorac. Surg. (1991)
- Cooperativity between platelet-activating factor and collagen in platelet aggregation. Kojima, S., Hagiwara, H., Soga, W., Sekiya, F., Saito, Y., Inada, Y. Biochem. Biophys. Res. Commun. (1987)
- Inflammatory effects of acetylglycerylether phosphorylcholine: vascular permeability increase and induction of pleurisy in rats. Oh, S., Hayashi, M., Yamaki, K. Prostaglandins, leukotrienes, and medicine. (1986)